PureTech Health Statistics

Total Valuation

PureTech Health has a market cap or net worth of GBP 409.89 million. The enterprise value is 120.80 million.

Market Cap	409.89M
Enterprise Value	120.80M

Important Dates

The next estimated earnings date is Thursday, November 28, 2024.

Earnings Date	Nov 28, 2024
Ex-Dividend Date	n/a

Share Statistics

PureTech Health has 239.42 million shares outstanding. The number of shares has decreased by -2.86% in one year.

Current Share Class	n/a
Shares Outstanding	239.42M
Shares Change (YoY)	-2.86%
Shares Change (QoQ)	-1.71%
Owned by Insiders (%)	6.62%
Owned by Institutions (%)	74.35%
Float	156.55M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	1.64
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.85
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.68, with a Debt / Equity ratio of 0.47.

Current Ratio	3.68
Quick Ratio	3.63
Debt / Equity	0.47
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.80

Financial Efficiency

Return on equity (ROE) is -22.07% and return on invested capital (ROIC) is -15.66%.

Return on Equity (ROE)	-22.07%
Return on Assets (ROA)	-13.39%
Return on Capital (ROIC)	-15.66%
Revenue Per Employee	4,115
Profits Per Employee	-725,032
Employee Count	90
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +3.88% in the last 52 weeks. The beta is 1.02, so PureTech Health's price volatility has been similar to the market average.

Beta (5Y)	1.02
52-Week Price Change	+3.88%
50-Day Moving Average	154.21
200-Day Moving Average	185.76
Relative Strength Index (RSI)	61.48
Average Volume (20 Days)	726,778

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PureTech Health had revenue of GBP 370,314 and -65.25 million in losses. Loss per share was -0.24.

Revenue	370,314
Gross Profit	-64.53M
Operating Income	-107.96M
Pretax Income	-61.24M
Net Income	-65.25M
EBITDA	-106.61M
EBIT	-107.96M
Loss Per Share	-0.24

Full Income Statement

Balance Sheet

The company has 395.96 million in cash and 114.52 million in debt, giving a net cash position of 281.44 million or 1.18 per share.

Cash & Cash Equivalents	395.96M
Total Debt	114.52M
Net Cash	281.44M
Net Cash Per Share	1.18
Equity (Book Value)	242.29M
Book Value Per Share	1.04
Working Capital	293.16M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-95.58M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-29,153.02%
Pretax Margin	-16,536.55%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PureTech Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.86%
Shareholder Yield	2.86%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PureTech Health has an Altman Z-Score of 1.32. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.32
Piotroski F-Score	n/a